Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
featured
Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754) Versus Placebo in Patients With Progressive Carcinoid Tumors

Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754) Versus Placebo in Patients With Progressive Carcinoid Tumors

  • 38 views
  • 08 Nov, 2020
  • 1 location
featured
Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors

Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors

  • 90 views
  • 08 Nov, 2020
  • 1 location
featured
Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

  • 140 views
  • 08 Nov, 2020
  • 1 location
Clinic Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE Groupe d' tude Des Tumeurs Endocrines)

Small intestine carcinoid tumors are rare. Small intestine Familial Carcinoid Tumors (FCT) are defined by the occurrence of at least 2 cases of this tumor type in first- or second-degree

  • 0 views
  • 22 Jan, 2021
  • 1 location
Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma

PRECISION-NEC is a single-center, open-label, pilot feasibility study of molecularly defined subtypes of metastatic high-grade neuroendocrine carcinoma (HG-NEC). The hypothesis is that HG-NEC (excluding small cell carcinoma) can be segregated based on mutational analysis and that next generation sequencing (NGS)-based assignment of therapy is feasible and will potentially improve the …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

: Endocrine carcinoma of pancreas and digestive tract.) (closed to accrual) Neuroendocrine carcinoma including carcinoid of the lung (closed to accrual 12/19/2017) Pheochromocytoma

gonadotrophin releasing hormone
bone scan
adenoid cystic carcinoma
neutrophil count
somatostatin
  • 6048 views
  • 24 Sep, 2021
  • 818 locations
18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years old) with congenital hyperinsulinism. Pediatric patients (less than 18 years old) with neuroblastoma. Pediatric (less than 18 years old) or Adult patients (18 or older) with …

  • 0 views
  • 29 Apr, 2021
  • 1 location
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice

The prognosis of lung cancer depends much on the stage of the disease at the time of diagnosis. Only 16 % of lung cancer can be offered curative intended surgery. Chest x-ray is the gate-keeper in lung cancer diagnosis, but it has a miss rate of 20-60 %. A false …

ct scan
x-rays
  • 3 views
  • 07 Nov, 2020
  • 2 locations
Cabozantinib and Nivolumab for Carcinoid Tumors

This research study, is studying the combination of cabozantinib and nivolumab in treating advanced carcinoid tumors. Carcinoid tumor is another term used to refer to

metastatic cancer
carcinoid tumor
line of therapy
neutrophil count
cabozantinib
  • 0 views
  • 30 Jan, 2021
An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a

ct scan
  • 0 views
  • 12 Aug, 2021
  • 1 location